139 related articles for article (PubMed ID: 3889230)
1. A randomized trial of adjuvant chemotherapy in head and neck cancer.
Taylor SG; Applebaum E; Showel JL; Norusis M; Holinger LD; Hutchinson JC; Murthy AK; Caldarelli DD
J Clin Oncol; 1985 May; 3(5):672-9. PubMed ID: 3889230
[TBL] [Abstract][Full Text] [Related]
2. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
Ervin TJ; Clark JR; Weichselbaum RR; Fallon BG; Miller D; Fabian RL; Posner MR; Norris CM; Tuttle SA; Schoenfeld DA
J Clin Oncol; 1987 Jan; 5(1):10-20. PubMed ID: 2433406
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
Clark JR; Busse PM; Norris CM; Andersen JW; Dreyfuss AI; Rossi RM; Poulin MD; Colevas AD; Tishler RB; Costello R; Lucarini JW; Lucarini D; Thornhill L; Lackey M; Peters E; Posner MR
J Clin Oncol; 1997 Sep; 15(9):3100-10. PubMed ID: 9294473
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
7. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program.
Jacobs C; Makuch R
J Clin Oncol; 1990 May; 8(5):838-47. PubMed ID: 2185340
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
[TBL] [Abstract][Full Text] [Related]
10. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
[TBL] [Abstract][Full Text] [Related]
13. An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer.
Ensley J; Kish J; Tapazoglou E; Jacobs J; Weaver A; Atkinson D; Ahmed K; Mathog R; Al-Sarraf M
J Clin Oncol; 1988 Jul; 6(7):1147-53. PubMed ID: 3292714
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in stage III and IV squamous cell carcinoma of the head and neck.
Klima A; Klippstein T; Bergmann L; Szepesi S; Ilberg CV
J Laryngol Otol; 1988 Apr; 102(4):337-40. PubMed ID: 2455011
[TBL] [Abstract][Full Text] [Related]
16. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF
J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
Sridhar KS; Ohnuma T; Biller H; Holland JF; Ambinder EP; Barba J
Am J Clin Oncol; 1985 Feb; 8(1):55-60. PubMed ID: 2581436
[TBL] [Abstract][Full Text] [Related]
18. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer.
Taylor SG; McGuire WP; Hauck WW; Showel JL; Lad TE
J Clin Oncol; 1984 Sep; 2(9):1006-11. PubMed ID: 6332178
[TBL] [Abstract][Full Text] [Related]
20. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
